Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1994 Oct;62(10):4226–4232. doi: 10.1128/iai.62.10.4226-4232.1994

Murine tissues exposed to cytotoxic drugs display altered patterns of Candida albicans adhesion.

J L López-Ribot 1, C S McVay 1, W L Chaffin 1
PMCID: PMC303099  PMID: 7927678

Abstract

An ex vivo adhesion assay was used to examine the binding of Candida albicans yeast cells to tissues from mice treated with cytotoxic drugs such as lipopolysaccharide and the clinically used anticancer drugs doxorubicin, cisplatin, and vincristine. No major differences were observed in binding of the fungal cells to liver and kidney tissues from treated or untreated animals. All drug-treated spleens displayed altered patterns of C. albicans adhesion compared with the control group, with yeast cells bound not only to the marginal zone but also to the white and red pulp. Immunostaining for macrophages, which are proposed as the site of normal adhesion, showed no apparent differences between the control and the experimental spleens that could account for the change in adhesion patterns. Scanning electron microscopy images suggested that yeast binding to the white pulp of treated tissue is mediated through fibers, perhaps extracellular matrix components exposed as result of the cytotoxic treatment. Exposure of new attachment sites for C. albicans in treated tissues may facilitate initiation of infection.

Full text

PDF
4226

Images in this article

4229Image
on p.4229
4230Image
on p.4230

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Austyn J. M., Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol. 1981 Oct;11(10):805–815. doi: 10.1002/eji.1830111013. [DOI] [PubMed] [Google Scholar]
  2. Bobichon H., Bussy V., Angiboust J. F., Manfait M., Bouchet P., Jardillier J. C. Candida albicans--adriamycin interactions: ultrastructural and spectrofluorometric study of whole yeasts and spheroplasts. Biol Cell. 1990;70(1-2):53–59. doi: 10.1016/0248-4900(90)90360-f. [DOI] [PubMed] [Google Scholar]
  3. Bouchara J. P., Tronchin G., Annaix V., Robert R., Senet J. M. Laminin receptors on Candida albicans germ tubes. Infect Immun. 1990 Jan;58(1):48–54. doi: 10.1128/iai.58.1.48-54.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brawner D. L., Mori M. Adherence of Candida albicans to tissues from mice with drug- or radiation-induced immunodeficiencies. J Infect Dis. 1992 Sep;166(3):587–597. doi: 10.1093/infdis/166.3.587. [DOI] [PubMed] [Google Scholar]
  5. Brawner D. L., Smith F. O., Mori M., Nonoyama S. Adherence of Candida albicans to tissues from mice with genetic immunodeficiencies. Infect Immun. 1991 Sep;59(9):3069–3078. doi: 10.1128/iai.59.9.3069-3078.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Calderone R. A., Braun P. C. Adherence and receptor relationships of Candida albicans. Microbiol Rev. 1991 Mar;55(1):1–20. doi: 10.1128/mr.55.1.1-20.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Calderone R. A. Recognition between Candida albicans and host cells. Trends Microbiol. 1993 May;1(2):55–58. doi: 10.1016/0966-842x(93)90033-n. [DOI] [PubMed] [Google Scholar]
  8. Chaffin W. L., Collins B., Marx J. N., Cole G. T., Morrow K. J., Jr Characterization of mutant strains of Candida albicans deficient in expression of a surface determinant. Infect Immun. 1993 Aug;61(8):3449–3458. doi: 10.1128/iai.61.8.3449-3458.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chohan V., Lowenthal R. M. Effect of vinblastine, vincristine, and vindesine on neutrophil phagocytosis and iodination. Cancer Treat Rep. 1982 Mar;66(3):505–508. [PubMed] [Google Scholar]
  10. Cutler J. E., Brawner D. L., Hazen K. C., Jutila M. A. Characteristics of Candida albicans adherence to mouse tissues. Infect Immun. 1990 Jun;58(6):1902–1908. doi: 10.1128/iai.58.6.1902-1908.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Han Y., van Rooijen N., Cutler J. E. Binding of Candida albicans yeast cells to mouse popliteal lymph node tissue is mediated by macrophages. Infect Immun. 1993 Aug;61(8):3244–3249. doi: 10.1128/iai.61.8.3244-3249.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hazen K. C., Brawner D. L., Riesselman M. H., Jutila M. A., Cutler J. E. Differential adherence of hydrophobic and hydrophilic Candida albicans yeast cells to mouse tissues. Infect Immun. 1991 Mar;59(3):907–912. doi: 10.1128/iai.59.3.907-912.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kanbe T., Cutler J. E. Evidence for adhesin activity in the acid-stable moiety of the phosphomannoprotein cell wall complex of Candida albicans. Infect Immun. 1994 May;62(5):1662–1668. doi: 10.1128/iai.62.5.1662-1668.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kanbe T., Han Y., Redgrave B., Riesselman M. H., Cutler J. E. Evidence that mannans of Candida albicans are responsible for adherence of yeast forms to spleen and lymph node tissue. Infect Immun. 1993 Jun;61(6):2578–2584. doi: 10.1128/iai.61.6.2578-2584.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kanbe T., Jutila M. A., Cutler J. E. Evidence that Candida albicans binds via a unique adhesion system on phagocytic cells in the marginal zone of the mouse spleen. Infect Immun. 1992 May;60(5):1972–1978. doi: 10.1128/iai.60.5.1972-1978.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Karabinis A., Hill C., Leclercq B., Tancrède C., Baume D., Andremont A. Risk factors for candidemia in cancer patients: a case-control study. J Clin Microbiol. 1988 Mar;26(3):429–432. doi: 10.1128/jcm.26.3.429-432.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Klotz S. A. Adherence of Candida albicans to components of the subendothelial extracellular matrix. FEMS Microbiol Lett. 1990 Mar 15;56(3):249–254. doi: 10.1016/s0378-1097(05)80049-7. [DOI] [PubMed] [Google Scholar]
  18. Klotz S. A., Maca R. D. Endothelial cell contraction increases Candida adherence to exposed extracellular matrix. Infect Immun. 1988 Sep;56(9):2495–2498. doi: 10.1128/iai.56.9.2495-2498.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Klotz S. A., Smith R. L. A fibronectin receptor on Candida albicans mediates adherence of the fungus to extracellular matrix. J Infect Dis. 1991 Mar;163(3):604–610. doi: 10.1093/infdis/163.3.604. [DOI] [PubMed] [Google Scholar]
  20. Klotz S. A., Smith R. L., Stewart B. W. Effect of an arginine-glycine-aspartic acid-containing peptide on hematogenous candidal infections in rabbits. Antimicrob Agents Chemother. 1992 Jan;36(1):132–136. doi: 10.1128/aac.36.1.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Knisley K. A., Weitlauf H. M. Compartmentalized reactivity of M3/38 (anti-Mac-2) and M3/84 (anti-Mac-3) in the uterus of pregnant mice. J Reprod Fertil. 1993 Mar;97(2):521–527. doi: 10.1530/jrf.0.0970521. [DOI] [PubMed] [Google Scholar]
  22. Komshian S. V., Uwaydah A. K., Sobel J. D., Crane L. R. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis. 1989 May-Jun;11(3):379–390. doi: 10.1093/clinids/11.3.379. [DOI] [PubMed] [Google Scholar]
  23. Li R. K., Cutler J. E. Chemical definition of an epitope/adhesin molecule on Candida albicans. J Biol Chem. 1993 Aug 25;268(24):18293–18299. [PubMed] [Google Scholar]
  24. López-Ribot J. L., Chaffin W. L. Binding of the extracellular matrix component entactin to Candida albicans. Infect Immun. 1994 Oct;62(10):4564–4571. doi: 10.1128/iai.62.10.4564-4571.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. López-Ribot J. L., Vespa M. N., Chaffin W. L. Adherence of Candida albicans germ tubes to murine tissues in an ex vivo assay. Can J Microbiol. 1994 Jan;40(1):77–81. doi: 10.1139/m94-013. [DOI] [PubMed] [Google Scholar]
  26. McGrath J. M., Stewart G. J. The effects of endotoxin on vascular endothelium. J Exp Med. 1969 May 1;129(5):833–848. doi: 10.1084/jem.129.5.833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Miyakawa Y., Kuribayashi T., Kagaya K., Suzuki M., Nakase T., Fukazawa Y. Role of specific determinants in mannan of Candida albicans serotype A in adherence to human buccal epithelial cells. Infect Immun. 1992 Jun;60(6):2493–2499. doi: 10.1128/iai.60.6.2493-2499.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Moussa N. M., Ghannoum M. A., Whittaker P. A., el-Ezaby M. S., Quraman S. Effects of cisplatin and two novel palladium complexes on Candida albicans. Microbios. 1990;62(252-253):165–178. [PubMed] [Google Scholar]
  29. Murphy J. W. Mechanisms of natural resistance to human pathogenic fungi. Annu Rev Microbiol. 1991;45:509–538. doi: 10.1146/annurev.mi.45.100191.002453. [DOI] [PubMed] [Google Scholar]
  30. Nicolson G. L., Custead S. E. Effects of chemotherapeutic drugs on platelet and metastatic tumor cell-endothelial cell interactions as a model for assessing vascular endothelial integrity. Cancer Res. 1985 Jan;45(1):331–336. [PubMed] [Google Scholar]
  31. Nielsen H. Effect of cis-platinum on human blood monocyte function in vitro. Cancer Immunol Immunother. 1984;18(3):223–225. doi: 10.1007/BF00205515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Nielsen H., Rørth M. Phagocytosis and killing of Candida albicans by blood monocytes from patients with non-seminomatous testicular carcinoma: effect of chemotherapy. Acta Pathol Microbiol Immunol Scand C. 1985 Apr;93(2):85–89. doi: 10.1111/j.1699-0463.1985.tb02927.x. [DOI] [PubMed] [Google Scholar]
  33. Palù G., Valisena S., Bertoloni G., Cera C., Palumbo M. A further insight into the mechanism of action of anthracycline antibiotics. Microbiologica. 1988 Oct;11(4):307–319. [PubMed] [Google Scholar]
  34. Peiris V., Oppenheim B. A. Antimicrobial activity of cytotoxic drugs may influence isolation of bacteria and fungi from blood cultures. J Clin Pathol. 1993 Dec;46(12):1124–1125. doi: 10.1136/jcp.46.12.1124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Ray T. L., Payne C. D. Scanning electron microscopy of epidermal adherence and cavitation in murine candidiasis: a role for Candida acid proteinase. Infect Immun. 1988 Aug;56(8):1942–1949. doi: 10.1128/iai.56.8.1942-1949.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Riesselman M. H., Kanbe T., Cutler J. E. Improvements and important considerations of an ex vivo assay to study Candida albicans-splenic tissue interactions. J Immunol Methods. 1991 Dec 15;145(1-2):153–160. doi: 10.1016/0022-1759(91)90321-6. [DOI] [PubMed] [Google Scholar]
  37. Sarachek A., Henderson L. A. Modification of responses of Candida albicans to cisplatin by membrane damaging antimycotic agents. Mycoses. 1991 Mar-Apr;34(3-4):177–182. doi: 10.1111/j.1439-0507.1991.tb00640.x. [DOI] [PubMed] [Google Scholar]
  38. Sarachek A., Henderson L., Wilkens W. E. Evaluation of the genotoxic spectrum of cisplatin for Candida albicans. Microbios. 1992;72(292-293):183–201. [PubMed] [Google Scholar]
  39. Schurig J. E., Florczyk A. P., Bradner W. T. The mouse as a model for predicting the myelosuppressive effects of anticancer drugs. Cancer Chemother Pharmacol. 1986;16(3):243–246. doi: 10.1007/BF00293985. [DOI] [PubMed] [Google Scholar]
  40. Silverstein R., Christoffersen C. A., Morrison D. C. Modulation of endotoxin lethality in mice by hydrazine sulfate. Infect Immun. 1989 Jul;57(7):2072–2078. doi: 10.1128/iai.57.7.2072-2078.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Skerl K. G., Calderone R. A., Segal E., Sreevalsan T., Scheld W. M. In vitro binding of Candida albicans yeast cells to human fibronectin. Can J Microbiol. 1984 Feb;30(2):221–227. doi: 10.1139/m84-033. [DOI] [PubMed] [Google Scholar]
  42. Walker E. M., Jr, Cannon D. J., Reifsteck M. E., Hobbs K. A., Hardin H. F., Jones M. M., Skeeles J. K. Effects of diethyldithiocarbamate and structural analogs in mice with systemic candidal infections. Res Commun Chem Pathol Pharmacol. 1987 May;56(2):253–263. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES